Get the Stockscreener App
7.54
2.58%
-0.20
After Hours:
7.54
Why is Monte Rosa Therapeutics Inc (GLUE) Stock down?
We've noticed a 8.73% decline in Monte Rosa Therapeutics Inc (GLUE) stock during the 2024-11-15 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
17 Oct, 2023:
Monte Rosa Therapeutics Stock (GLUE) dropped by 19.80% from $5.00 to $4.01 in the trading on Tuesday October 17, 2023. The reason why GLUE stock down today is due to interim data. The company announced interim data from the Phase 1 dose escalation part of its ongoing Phase 1/2 open-label, multicenter study of MRT-2359 in patients with MYC-driven solid tumors, including lung cancers and high-grade neuroendocrine cancer.
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):